31st week of 2017 patent applcation highlights part 10 |
Patent application number | Title | Published |
20170216230 | METHOD FOR ENHANCING IMMUNITY, INHIBITING ALLERGIC REACTION, AND/OR INHIBITING AUTOIMMUNE REACTION | 2017-08-03 |
20170216231 | COMBINATION OF ADAPALENE AND BENZOYL PEROXIDE FOR THE TREATMENT OF SEVERE ACNE | 2017-08-03 |
20170216232 | TREATING CRITICALLY ILL PATIENTS WITH INTRAVENOUS IBUPROFEN | 2017-08-03 |
20170216233 | ANTIMICROBIALS AND METHODS OF USE THEREOF | 2017-08-03 |
20170216234 | BENZOATES FOR USE IN TREATING DEMENTIA | 2017-08-03 |
20170216235 | ADMINISTRATION OF ADAPALENE AND BENZOYL PEROXIDE FOR THE LONG-TERM TREATMENT OF ACNE VULGARIS | 2017-08-03 |
20170216236 | Controlled Release Dosage Form | 2017-08-03 |
20170216237 | MONOUNSATURATED FATTY ACID COMPOSITIONS AND USE FOR TREATING ATHEROSCLEROSIS | 2017-08-03 |
20170216238 | Compounds and Methods for Modulating Vascular Injury | 2017-08-03 |
20170216239 | EICOSAPENTAENOIC ACID-PRODUCING MICROORGANISMS, FATTY ACID COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF | 2017-08-03 |
20170216240 | METHODS FOR MODULATING IKS CHANNEL ACTIVITY | 2017-08-03 |
20170216241 | ALPHA- AND GAMMA-TRUXILLIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF | 2017-08-03 |
20170216242 | METHODS OF TREATING HEART FAILURE DISEASES USING PRODRUGS OF METHYL HYDROGEN FUMARATE | 2017-08-03 |
20170216243 | PARENTERAL DOSAGE FORM OF AMIODARONE | 2017-08-03 |
20170216244 | METHODS FOR TREATING DIABETIC NEPHROPATHY | 2017-08-03 |
20170216245 | Polyphenol Compositions | 2017-08-03 |
20170216246 | METHOD FOR TREATING ZIKA VIRUS INFECTION WITH QUERCETIN-CONTAINING COMPOSITIONS | 2017-08-03 |
20170216247 | USES OF DULOXETINE HCL MEDICAMENT IN PREPARING PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER | 2017-08-03 |
20170216248 | Enhanced Erythropoiesis and Iron Metabolism | 2017-08-03 |
20170216249 | Substituted Phenyl Aziridine Precursor Analogs for Inhibiting Androgen-Independent Prostate Cancer Cell Growth | 2017-08-03 |
20170216250 | METHODS OF TREATING DIABETES BY ADMINISTERING A GLUCAGON RECEPTOR ANTAGONIST IN COMBINATION WITH A CHOLESTEROL ABSORPTION INHIBITOR | 2017-08-03 |
20170216251 | USE OF (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE TO TREAT ADDICTIVE AND ALCOHOL-RELATED DISORDERS | 2017-08-03 |
20170216252 | ANTI-BACTERIAL PYRUVATE KINASE MODULATOR COMPOUNDS, COMPOSITIONS, USES AND METHODS | 2017-08-03 |
20170216253 | KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR PREVENTING OCULAR PAIN | 2017-08-03 |
20170216254 | FK506 DERIVATIVE MAINTAINING NERVE REGENERATION ACTIVITY WITHOUT IMMUNOSUPPRESSIVE ACTIVITY, AND USE THEREOF | 2017-08-03 |
20170216255 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | 2017-08-03 |
20170216256 | METHOD OF TREATING A CNS DISORDER USING A WATER-SOLUBLE HISTONE DEACETYLASE INHIBITOR | 2017-08-03 |
20170216257 | NOVEL SUBSTITUTED BICYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS | 2017-08-03 |
20170216258 | MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY | 2017-08-03 |
20170216259 | COMPOSITIONS AND METHODS FOR TARGETING RECEPTORS EXPRESSED IN THE GUT | 2017-08-03 |
20170216260 | OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION | 2017-08-03 |
20170216261 | COMBINATION THERAPY USING AZABICYCLO COMPOUND FOR CANCER | 2017-08-03 |
20170216262 | AMIDO SPIROCYCLIC AMIDE AND SULFONAMIDE DERIVATIVES | 2017-08-03 |
20170216263 | ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS | 2017-08-03 |
20170216264 | SUBSTITUTED MACROCYCLES USEFUL AS KINASES INHIBITORS AND METHODS OF USE THEREOF | 2017-08-03 |
20170216265 | INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR MODULATING HEMATOPOIETIC STEM CELLS AND HEMATOPOIESIS | 2017-08-03 |
20170216266 | MULTI-COMPONENT CRYSTALS OF VISMODEGIB AND SELECTED CO-CRYSTAL FORMERS OR SOLVENTS | 2017-08-03 |
20170216267 | CONTROLLED DELIVERY SYSTEM | 2017-08-03 |
20170216268 | GEL CONTAINING PIRFENIDONE | 2017-08-03 |
20170216269 | METHODS OF TREATING DEVELOPMENTAL DISORDERS USING PIPRADROL | 2017-08-03 |
20170216270 | Methylphenidate Extended Release Chewable Tablet | 2017-08-03 |
20170216271 | SALTS OF HETEROCYCLIC MODULATORS OF HIF ACTIVITY FOR TREATMENT OF DISEASE | 2017-08-03 |
20170216272 | COMPOSITIONS FOR TREATING OR PREVENTING OBESITY AND INSULIN RESISTANCE DISORDERS | 2017-08-03 |
20170216273 | Nicotine Derivatives and Methods of Use | 2017-08-03 |
20170216274 | Enhanced Erythropoiesis and Iron Metabolism | 2017-08-03 |
20170216275 | PHOSPHODIESTERASE INHIBITORS AND USES THEREOF | 2017-08-03 |
20170216276 | METHODS AND THERAPEUTIC COMBINATIONS FOR TREATING TUMORS | 2017-08-03 |
20170216277 | THERAPEUTIC USE OF NALBUPHINE WITHOUT AQUARETIC EFFECTS | 2017-08-03 |
20170216278 | TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE | 2017-08-03 |
20170216279 | METHODS FOR TREATING DEPRESSIVE SYMPTOMS | 2017-08-03 |
20170216280 | SUBSTITUTED DIKETOPIPERAZINE ANALOGS FOR USE AS DRUG DELIVERY AGENTS | 2017-08-03 |
20170216281 | OPTICAL CORRECTION | 2017-08-03 |
20170216282 | Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders | 2017-08-03 |
20170216283 | COMPOUNDS AND USES | 2017-08-03 |
20170216284 | ANTIVIRAL THERAPY | 2017-08-03 |
20170216285 | SMALL MOLECULE INHIBITORS FOR CANCER THERAPY | 2017-08-03 |
20170216286 | KILLING SENESCENT CELLS AND TREATING SENESCENCE-ASSOCIATED CONDITIONS USING A SRC INHIBITOR AND A FLAVONOID | 2017-08-03 |
20170216287 | TREATING NEURAL DISEASE WITH TYROSINE KINASE INHIBITORS | 2017-08-03 |
20170216288 | IMMUNOPOTENTIATOR POTENTIATING TUMOR IMMUNITY OR INFECTION IMMUNITY | 2017-08-03 |
20170216289 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | 2017-08-03 |
20170216290 | HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME | 2017-08-03 |
20170216291 | ALDOSE REDUCTASE INHIBITORS AND USES THEREOF | 2017-08-03 |
20170216292 | ALDOSE REDUCTASE INHIBITORS AND USES THEREOF | 2017-08-03 |
20170216293 | THIENOPYRIMIDINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2017-08-03 |
20170216294 | Methotrexate for Proliferative Vitreoretinopathy | 2017-08-03 |
20170216295 | CCR9 ANTAGONIST COMPOUNDS | 2017-08-03 |
20170216296 | METHODS OF TREATING HYPERGLYCEMIA | 2017-08-03 |
20170216297 | EFFICIENT INHIBITION OF HSP27 | 2017-08-03 |
20170216298 | Beta2-ADRENOCEPTOR AGONIST FOR THE TREATMENT OF COUGH | 2017-08-03 |
20170216299 | 3-(3H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-C]PYRIDINE AND THERAPEUTIC USES THEREOF | 2017-08-03 |
20170216300 | EZH2 INHIBITORS FOR TREATING LYMPHOMA | 2017-08-03 |
20170216301 | NOVEL BICYCLIC BROMODOMAIN INHIBITORS | 2017-08-03 |
20170216302 | METHOD FOR TREATING CANCER BY COMBINED USE | 2017-08-03 |
20170216303 | PHENOXY ACETIC ACIDS AND PHENYL PROPIONIC ACIDS AS PPAR DELTA AGONISTS | 2017-08-03 |
20170216304 | 2-(MORPHOLIN-4-YL)-1,7-NAPHTHYRIDINES | 2017-08-03 |
20170216305 | COMPOSITIONS COMPRISING MELOXICAM-CYCLODEXTRIN INCLUSION COMPLEXES AND METHODS OF TREATING ACUTE PAIN | 2017-08-03 |
20170216306 | A Use of Alkaloid in Preparing Pharmaceutical Compositions for Preventing or Treating Pulmonary Fibrosis | 2017-08-03 |
20170216307 | ADMINISTRATION OF AN ANTI-OBESITY COMPOUND TO INDIVIDUALS WITH RENAL IMPAIRMENT | 2017-08-03 |
20170216308 | POLYMER CONJUGATE FOR DELIVERY OF A BIOACTIVE AGENT | 2017-08-03 |
20170216309 | NANOSTRUCTURED FORMULATIONS FOR THE DELIVERY OF SILIBININ AND OTHER ACTIVE INGREDIENTS FOR TREATING OCULAR DISEASES | 2017-08-03 |
20170216310 | VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS | 2017-08-03 |
20170216311 | HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS | 2017-08-03 |
20170216312 | STERODIAL COMPOSITIONS | 2017-08-03 |
20170216313 | ORAL FORMULATION OF A-NOR-5a ANDROSTANE COMPOUND | 2017-08-03 |
20170216314 | TOPICAL FORMULATIONS | 2017-08-03 |
20170216315 | USES OF ERGOSTATRIEN-3beta-OL | 2017-08-03 |
20170216316 | FARNESOID X RECEPTOR MODULATORS | 2017-08-03 |
20170216317 | COMBINATION THERAPIES AND METHODS OF USE THEREOF FOR TREATING CANCER | 2017-08-03 |
20170216318 | PHARMACEUTICAL COMPOSITIONS COMPRISING ACTIVE DRUGS, CONTRACEPTIVE KITS COMPRISING ACTIVE DRUGS, AND METHODS OF ADMINISTERING THE SAME | 2017-08-03 |
20170216319 | Treating Various Disorders Using TrkB Agonists | 2017-08-03 |
20170216320 | ASPIRIN FORMULATION FOR INCREASED EFFICACY | 2017-08-03 |
20170216321 | LIQUID FORMULATIONS OF COMPOUNDS ACTIVE AT SULFONYLUREA RECEPTORS | 2017-08-03 |
20170216322 | NATURAL MARINE SOURCE PHOSPHOLIPIDS COMPRISING POLYUNSATURATED FATTY ACIDS AND THEIR APPLICATIONS | 2017-08-03 |
20170216323 | Methods for Treating Viral Infections Using Hydrogen Sulfide Donors | 2017-08-03 |
20170216324 | Osteoclast Inhibitors Such as Zoledronic Acid for Low Back Pain Treatment | 2017-08-03 |
20170216325 | (R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZ- YL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS | 2017-08-03 |
20170216326 | USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLOGICAL DISEASES | 2017-08-03 |
20170216327 | COMPOUNDS AND NAIL POLISH | 2017-08-03 |
20170216328 | METHODS AND COMPOSITIONS FOR MICROBIOME ALTERATION | 2017-08-03 |
20170216329 | Ceramide-Rubusoside Nanomicelles and Their Use in Cancer Therapy | 2017-08-03 |